Study of combination chemotherapy of CPT-11 [irinotecan]/S-1 after anthracycline and taxane in recurrent or metastatic breast cancer (JBCRG-M01).
Phase of Trial: Phase I/II
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 01 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.